Global Interventional Cardiology Devices Market (2018-2023)

Array
(
    [id] => 1776538
    [discount] => ENTERPRISE WIDE LICENCE-30--------
    [isbn] => 
    [title] => Global Interventional Cardiology Devices Market (2018-2023)
    [upcommingtext] => 
    [seo_url] => global-interventional-cardiology-devices-market
    [shortdesc] => 
    [meta_title] => Global Interventional Cardiology Devices Market (2018-2023)
    [keyword] => Global Interventional Cardiology Devices Market,  Interventional Cardiology Devices Market size, Interventional Cardiology Devices Market forecast, Interventional Cardiology Devices Market report, Interventional Cardiology Devices Market growth
    [description] => Global Interventional Cardiology Devices Market (2018-2023) market research report available in single user pdf license with Aarkstore Enterprise at USD 2950
    [curr] => USD
    [category] => 1200
    [publisher] => 48
    [published_date] => 2019-08-22
    [country] => 230
    [author_name] => 
    [page_num] => 60
    [abstract] => 

The interventional cardiology devices market is a multi-billion-dollar market which includes, but is not limited to, drug-eluting stents, catheters, bare-metal stents, guidewires, and percutaneous transluminal coronary angioplasty. The intervention cardiology devices market provides treatment for a range of cardiovascular diseases including coronary artery disease, peripheral vascular disease, and heart valve disease. The global interventional cardiology devices market is anticipated to expand at a CAGR of 6.04% during the 2018-2023 period, and will reach a value of USD 15.43 Bn by 2023. Rising incidence of cardiovascular diseases, along with the adoption of minimally invasive surgeries is expected to drive the interventional cardiology devices market during the forecast period.
 

Segmentation based on product type
Based on product type, the drug-eluting stents segment contributed the highest revenue in 2018, by replacing the bare-metal stents market, owing to major technological advancements. The segment is anticipated to register a CAGR of 5.71% during the 2018-2023 period, to reach USD 6.71 Bn by 2023. Catheters being the major medium of interventional cardiology procedures, its segment holds a market share of ~27%. The segment is expected to expand at the highest CAGR (7.02%) during the forecast period.

Regional insights
North America accounted for ~38% of the total revenue of the interventional cardiology devices market in 2018, followed by Asia-Pacific (~27%). The Asia-Pacific region is anticipated to expand at the highest CAGR (6.94%) during the forecast period, followed by Latin America, and the Middle East and Africa, expanding at CAGRs of 6.54% and 6.29% respectively. Most of Asia-Pacific’s growth is estimated to come from China, Japan, and India due to the increasing incidence of cardiovascular diseases and rising number of diabetic patients.

Companies profiled
Abbott Laboratories
Boston Scientific Corporation
Medtronic
Terumo Corporation
Edwards Lifesciences Corporation
Becton Dickinson
Johnson & Johnson
B. Braun Melsungen
Teleflex Incorporated
MicroPort Scientific Corporation
 

[table_of_contents] =>

Chapter 1: Executive Summary

1.1. Market scope and segmentation

1.2. Key questions answered in the study

1.3. Executive summary

Chapter 2: Introduction

2.1. Market definitions

2.2. Market trends

2.3. Market drivers

2.4. Market challenges

2.5. Revenue based on product type - (USD Bn) (2018)

2.6. Value chain analysis of the global interventional cardiology devices market

Chapter 3: Global interventional cardiology devices market overview

3.1. Market overview

3.1.1. Global historical market revenue (USD Bn) (2016-2017)

3.1.2. Global forecast market revenue (USD Bn) (2018-2023)

3.1.3. Geography-wise market revenue (USD Bn) (2018 and 2023)

Chapter 4: Global interventional cardiology devices market - based on product type

4.1. Drug-eluting stents market

4.1.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.1.2. Trends

4.1.3. Drivers

4.2. Catheters market

4.2.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.2.2. Trends

4.2.3. Drivers

4.3. Bare-metal stents market

4.3.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.3.2. Trends

4.3.3. Drivers

4.4. Guidewires market

4.4.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.4.2. Trends

4.4.3. Drivers

4.5. Other interventional cardiology devices market

4.5.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.5.2. Trends

4.5.3. Drivers

Chapter 5: Global interventional cardiology devices market - based on regions

5.1. North America

5.1.1. Overview

5.1.2. Revenue - (2015-2023) (USD Bn)

5.1.3. Key highlights

5.2. Europe

5.2.1. Overview

5.2.2. Revenue - (2015-2023) (USD Bn)

5.2.3. Key highlights

5.3. Asia-Pacific

5.3.1. Overview

5.3.2. Revenue - (2015-2023) (USD Bn)

5.3.3. Key highlights

5.4. Latin America

5.4.1. Overview

5.4.2. Revenue - (2015-2023) (USD Bn)

5.4.3. Key highlights

5.5. The Middle East and Africa

5.5.1. Overview

5.5.2. Revenue - (2015-2023) (USD Bn)

5.5.3. Key highlights

Chapter 6: Market share of companies

6.1. Companies’ share in the global interventional cardiology devices market

Chapter 7: Competitive landscape

7.1. Abbott Laboratories

7.1.1. Company snapshot

7.1.2. Key financials

7.1.3. Business description and major products

7.1.4. Global presence

7.1.5. Major initiatives

7.1.6. Growth strategies

Note: Similar information areas will be covered for the competitors

7.2. Boston Scientific Corporation

7.3. Medtronic

7.4. Terumo Corporation

7.5. Edwards Lifesciences Corporation

7.6. Becton Dickinson

7.7. Johnson & Johnson

7.8. B. Braun Melsungen

7.9. Teleflex Incorporated

7.10. MicroPort Scientific Corporation

Chapter 8: Conclusion

8.1. Conclusion

Chapter 9: Appendix

9.1. List of tables

9.2. Assumptions

9.3. Research methodology

9.4. About Research On Global Markets

9.5. Disclaimer
 

[list_of_tables] => [list_of_figures] => [sample_page] => [brochure] => [new_price] => ENTERPRISE WIDE LICENCE-2950 )
discount aarkstore

The interventional cardiology devices market is a multi-billion-dollar market which includes, but is not limited to, drug-eluting stents, catheters, bare-metal stents, guidewires, and percutaneous transluminal coronary angioplasty. The intervention cardiology devices market provides treatment for a range of cardiovascular diseases including coronary artery disease, peripheral vascular disease, and heart valve disease. The global interventional cardiology devices market is anticipated to expand at a CAGR of 6.04% during the 2018-2023 period, and will reach a value of USD 15.43 Bn by 2023. Rising incidence of cardiovascular diseases, along with the adoption of minimally invasive surgeries is expected to drive the interventional cardiology devices market during the forecast period.
 

Segmentation based on product type
Based on product type, the drug-eluting stents segment contributed the highest revenue in 2018, by replacing the bare-metal stents market, owing to major technological advancements. The segment is anticipated to register a CAGR of 5.71% during the 2018-2023 period, to reach USD 6.71 Bn by 2023. Catheters being the major medium of interventional cardiology procedures, its segment holds a market share of ~27%. The segment is expected to expand at the highest CAGR (7.02%) during the forecast period.

Regional insights
North America accounted for ~38% of the total revenue of the interventional cardiology devices market in 2018, followed by Asia-Pacific (~27%). The Asia-Pacific region is anticipated to expand at the highest CAGR (6.94%) during the forecast period, followed by Latin America, and the Middle East and Africa, expanding at CAGRs of 6.54% and 6.29% respectively. Most of Asia-Pacific’s growth is estimated to come from China, Japan, and India due to the increasing incidence of cardiovascular diseases and rising number of diabetic patients.

Companies profiled
Abbott Laboratories
Boston Scientific Corporation
Medtronic
Terumo Corporation
Edwards Lifesciences Corporation
Becton Dickinson
Johnson & Johnson
B. Braun Melsungen
Teleflex Incorporated
MicroPort Scientific Corporation
 

Chapter 1: Executive Summary

1.1. Market scope and segmentation

1.2. Key questions answered in the study

1.3. Executive summary

Chapter 2: Introduction

2.1. Market definitions

2.2. Market trends

2.3. Market drivers

2.4. Market challenges

2.5. Revenue based on product type - (USD Bn) (2018)

2.6. Value chain analysis of the global interventional cardiology devices market

Chapter 3: Global interventional cardiology devices market overview

3.1. Market overview

3.1.1. Global historical market revenue (USD Bn) (2016-2017)

3.1.2. Global forecast market revenue (USD Bn) (2018-2023)

3.1.3. Geography-wise market revenue (USD Bn) (2018 and 2023)

Chapter 4: Global interventional cardiology devices market - based on product type

4.1. Drug-eluting stents market

4.1.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.1.2. Trends

4.1.3. Drivers

4.2. Catheters market

4.2.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.2.2. Trends

4.2.3. Drivers

4.3. Bare-metal stents market

4.3.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.3.2. Trends

4.3.3. Drivers

4.4. Guidewires market

4.4.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.4.2. Trends

4.4.3. Drivers

4.5. Other interventional cardiology devices market

4.5.1. Revenue - (2015, 2018 and 2023) (USD Bn)

4.5.2. Trends

4.5.3. Drivers

Chapter 5: Global interventional cardiology devices market - based on regions

5.1. North America

5.1.1. Overview

5.1.2. Revenue - (2015-2023) (USD Bn)

5.1.3. Key highlights

5.2. Europe

5.2.1. Overview

5.2.2. Revenue - (2015-2023) (USD Bn)

5.2.3. Key highlights

5.3. Asia-Pacific

5.3.1. Overview

5.3.2. Revenue - (2015-2023) (USD Bn)

5.3.3. Key highlights

5.4. Latin America

5.4.1. Overview

5.4.2. Revenue - (2015-2023) (USD Bn)

5.4.3. Key highlights

5.5. The Middle East and Africa

5.5.1. Overview

5.5.2. Revenue - (2015-2023) (USD Bn)

5.5.3. Key highlights

Chapter 6: Market share of companies

6.1. Companies’ share in the global interventional cardiology devices market

Chapter 7: Competitive landscape

7.1. Abbott Laboratories

7.1.1. Company snapshot

7.1.2. Key financials

7.1.3. Business description and major products

7.1.4. Global presence

7.1.5. Major initiatives

7.1.6. Growth strategies

Note: Similar information areas will be covered for the competitors

7.2. Boston Scientific Corporation

7.3. Medtronic

7.4. Terumo Corporation

7.5. Edwards Lifesciences Corporation

7.6. Becton Dickinson

7.7. Johnson & Johnson

7.8. B. Braun Melsungen

7.9. Teleflex Incorporated

7.10. MicroPort Scientific Corporation

Chapter 8: Conclusion

8.1. Conclusion

Chapter 9: Appendix

9.1. List of tables

9.2. Assumptions

9.3. Research methodology

9.4. About Research On Global Markets

9.5. Disclaimer
 


Theranostics: Global Markets

Report Scope:This report provides an updated review of theranostics, including materials, equipment, and strategies, and identifies current and emerging applications for theranostic products.It delineates the current market status for theranostics,

USD 5500 View Report

2020 Global Molecular Diagnostics Market: US, Europe, Japan--Supplier Sales and Market Shares by Product and Country, Competitive Profiles

This unique report provides Supplier Sales and market share estimates for major suppliers of molecular diagnostic products by country.The report also presents strategic assessments of major suppliers and emerging market

USD 6500 View Report

Global Pediatric Interventional Cardiology Equipment Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries

The Global market for Pediatric Interventional Cardiology Equipment is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach USD X.X million in

USD 2960 View Report

Global Interventional Neurology Device Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries

The Global market for Interventional Neurology Device is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach USD X.X million in 2027,

USD 2960 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available